Newsroom

比利時根特--(BUSINESS WIRE)--(美國商業資訊)-- 臨床階段生物製藥公司MRM Health NV是用於發炎性疾病和免疫腫瘤學的微生物組療法領域的先驅。該公司今日宣布，其核心研發計畫MH002的新藥臨床試驗申請(IND)已獲得美國食品藥物管理局(FDA)核准。此舉將支援STARFISH-UC第2b期臨床試驗的啟動，該試驗針對輕中度潰瘍性結腸炎病患展開，代表發炎性腸道疾病(IBD)下一代療法的研發邁出關鍵一步。 關於STARFISH-UC第2b期臨床試驗 STARFISH-UC試驗是一項隨機、雙盲、安慰劑對照研究，旨在驗證MH002在第2a期研究中觀察到的良好療效訊號和安全性特徵。MH002是一種經合理設計的活體微生物群落製劑，也是同類產品中最先進的活體生物治療產品(LBP)，它透過六種特徵明確的共生菌株協同作用，標靶作用於疾病特異性機制。該研究(NCT07296315)計畫招募約204名輕中度潰瘍性結腸炎(UC)病患，這些病患接受目前標準療法（5-氨基水楊酸(5 ASA)單藥治療，或聯合低劑量類固醇治療）後病情控制不佳。試驗將在歐洲和美國同步展開，包含為期12周的安慰...

比利时根特--(BUSINESS WIRE)--(美国商业资讯)-- 临床阶段生物制药公司MRM Health NV是用于炎症性疾病和免疫肿瘤学的微生物组疗法领域的先驱。该公司今日宣布，其核心研发项目MH002的新药临床试验申请(IND)已获得美国食品药品管理局(FDA)批准。此举将支持STARFISH-UC 2b期临床试验的启动，该试验针对轻中度溃疡性结肠炎患者展开，标志着炎症性肠病(IBD)下一代疗法的研发迈出关键一步。 关于STARFISH-UC 2b期临床试验 STARFISH-UC试验是一项随机、双盲、安慰剂对照研究，旨在验证MH002在2a期研究中观察到的良好疗效信号和安全性特征。MH002是一种经合理设计的活体微生物群落制剂，也是同类产品中最先进的活体生物治疗产品(LBP)，它通过六种特征明确的共生菌株协同作用，靶向作用于疾病特异性机制。该研究(NCT07296315)计划入组约204名轻中度溃疡性结肠炎(UC)患者，这些患者接受当前标准疗法（5-氨基水杨酸(5 ASA)单药治疗，或联合低剂量类固醇治疗）后病情控制不佳。试验将在欧洲和美国同步开展，包含为期12周的安慰剂对...

DENVER--(BUSINESS WIRE)--Royal Gold Presenting at the 29th Annual CIBC Western Institutional Conference...

CHICAGO--(BUSINESS WIRE)--The Board of Directors of Duff & Phelps Utility and Infrastructure Fund Inc. (NYSE: DPG), a closed-end fund advised by Duff & Phelps Investment Management Co., previously announced the following monthly distribution on September 18, 2025: Per Share Amount Ex-Date Record Date Payable Date $0.07 December 31, 2025 December 31, 2025 January 12, 2026 The Fund adopted a managed distribution plan (the “Plan”) in 2015. Under the Plan, the Fund will distribute all avail...

HOUSTON--(BUSINESS WIRE)--Helix Energy Solutions Group, Inc. (NYSE: HLX) announced today that it will participate in the Fearnley Securities Annual Offshore Drilling & Services Seminars in New York at the Peninsula Hotel on Wednesday, January 14, 2026, and in London at the Connaught Hotel on Thursday, January 15, 2026. Any investor presentation provided during the event will be publicly available and may be accessed on Helix’s website, www.helixesg.com. About Helix Helix Energy Solutions Gr...

DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report fourth quarter 2025 financial results after the close of trading on the New York Stock Exchange on Monday, February 2, 2026. Healthpeak will host a conference call and webcast on Tuesday, February 3, 2026 at 8:00 a.m. Mountain Time (10:00 a.m. Eastern Time) to review its financial performance and operating results...

CHICAGO--(BUSINESS WIRE)--The Board of Directors of DNP Select Income Fund Inc. (NYSE: DNP), a closed-end fund advised by Duff & Phelps Investment Management Co. (the “Adviser”), previously announced the following monthly distribution on September 18, 2025: Per Share Amount Ex-Date Record Date Payable Date $0.065 December 31, 2025 December 31, 2025 January 12, 2026 The Fund adopted a managed distribution plan (the “Plan”) in 2007. Under the Plan, the Fund will distribute all available inves...

BOCA RATON, Fla.--(BUSINESS WIRE)--Il Cataltheia Group e la sua controllata, Bruno Vision Care LLC, azienda leader nell'innovazione della salute degli occhi, oggi ha annunciato che la Food and Drug Administration (FDA) statunitense ha approvato la prima e unica lente a contatto morbida per la presbiopia che utilizza la tecnologia brevettata di progettazione ottica Extended Depth of Focus (EDOF), dando il via alla distribuzione commerciale negli Stati Uniti. Deseyne® offre una focalizzazione flu...

SAN DIEGO--(BUSINESS WIRE)--Jack in the Box Inc. (NASDAQ: JACK) (the “Company”) today announced it has repaid $105 million of the Company’s existing Series 2019-1 4.476% Fixed Rate Senior Secured Notes, Class A-2-II. The repayment was made in connection with the Company’s ongoing prioritization of debt reduction as part of its “JACK on Track” plan. “This debt repayment reflects the meaningful progress we continue to make toward strengthening our balance sheet and positioning the Company for sus...

PHILADELPHIA--(BUSINESS WIRE)--IGR Declares Monthly Distributions for January, February and March 2026 and Announces a Webinar with Portfolio Management...